Drug prohibition law is
prohibition-based law by
which
governments prohibit, except under
licence, the production, supply, and
possession of many, but not all, substances which are recognised as
drugs, and which corresponds to international
treaty commitments in the
Single Convention on
Narcotic Drugs 1961, the
Convention on
Psychotropic Substances 1971, and the
United Nations Convention Against Illicit Traffic in Narcotic Drugs
and Psychotropic Substances 1988.
When produced, supplied or possessed under licence, otherwise
prohibited drugs are known as controlled drugs.
The
United Nations has its own drug control
programme, as part of the United
Nations Office on Drugs and Crime
(UNODC), which was formerly called the United
Nations Office for Drug Control and Crime Prevention (ODCCP), and
the Commission on Narcotic
Drugs is the central drug policy-making body within the United
Nations system.
The
International
Narcotics Control Board (INCB) is an independent and
quasi-judicial control organ for the
implementation of the United Nations drug control
conventions.
It is important to note that there are several different sets of
"schedules", or lists, of controlled drugs. One is the INCB
schedules
(four schedules numbered I-IV), while another is the United States'
Controlled Substances Act
schedules
of controlled substances (five schedules, numbered I-V). Other
countries also have different classifications and numbers of lists,
such as those of the
United Kingdom
and
Canada.
History and founding principles
Drug prohibition law is based on the view that some drugs, notably
opium poppy,
coca
and substances derived from these
plants, are
so
addictive or dependence inducing and so
dangerous, in terms of potential effects on the
health,
morality and
behaviour of users, that they should be rarely, if
ever, used.
Psychotropic substances
covered by drug control law include
psilocybin mushrooms and
lysergic acid diethylamide
(LSD).
The following treaties are no longer in force, being superseded in
1961 by the
Single
Convention on Narcotic Drugs:
Licensing
Otherwise prohibited drugs may be licensed for medical, research
and industrial purposes.
Pharmaceutical companies,
also known as drug companies, work under drug control
licences.
Hemp production from
cannabis is an example of an industrial
purpose.
Recreational and self-medicational drug use
Recreational use and
self-medicational use are not licensed under
drug prohibition laws, although other drugs, not covered by such
laws, may be legally available for this purpose.
Alcohol and
tobacco are
notable examples of legally available recreational drugs.
Aspirin is an example of a drug legally available
for self-medicational purposes.
Health, moral, and behavior issues, and, therefore, legal issues,
are associated with alcohol and tobacco use, but these are not
addressed through drug prohibition laws.
In some jurisdictions, addiction to a prohibited drug may be
considered a legitimate reason for using it, provided the drug is
obtained from a licensed source, or a substitute may be provided,
for example,
methadone instead of
heroin. Generally, however, those addicted to
prohibited drugs are expected to find other ways of coping with
their addictions, or to risk suffering the law enforcement
penalties associated with illegal possession.
Enforcement
There is an extensive illegal trans-national industry supplying
prohibited drugs for recreational use. Thus, while drug prohibition
laws remain in force, there is perpetual law enforcement action
directed against the illegal industry, which impacts also on supply
for self-medication.
Although it is directed against illegal recreational drugs, and not
against drugs licensed under prohibition laws or against drugs
beyond the scope of prohibition laws, the law enforcement is
sometimes called the
war on
drugs.
Criticism
In the
United
Kingdom
, where the principle piece of drug prohibition
legislation is the Misuse of
Drugs Act 1971, criticism includes:
- Drug
classification: making a hash of it?, Fifth Report of
Session 2005–06, House of Commons Science and Technology
Committee, which said that the present system of drug
classification is based on historical assumptions, not scientific
assessment
- Development of a rational scale to assess the harm of drugs
of potential misuse, David Nutt, Leslie A. King, William
Saulsbury, Colin Blakemore, The Lancet,
24 March 2007, said the act is "not fit for purpose" and "the
exclusion of alcohol and tobacco from the Misuse of Drugs Act is,
from a scientific perspective, arbitrary"
List by jurisdiction of principal drug prohibition laws
External links
Notes and references
- Single Convention on Narcotic Drugs, 1961,
United Nations Office on Drugs and Crime (UNODC) website, accessed
6 February 2009
- Convention on Psychotropic Substances, 1971,
United Nations Office on Drugs and Crime (UNODC) website, accessed
6 February 2009
- Convention against the Illicit Traffic in
Narcotic Drugs and Psychotropic Substances, 1988, United
Nations Office on Drugs and Crime (UNODC) website, accessed 6
February 2009
- About UNODC, United Nations Office on
Drugs and Crime website, accessed 9 February 2009
- The Commission on Narcotic Drugs, United Nations
Office on Drugs and Crime website, accessed 13 February
2009
- International
Narcotics Control Board website, accessed 13 February 2009
- Misuse of Drugs Act 1971 (c.38), the text
of the act, OPSI website, accessed 27 January 2009
- Drug classification: making a hash of it?,
Fifth Report of Session 2005–06, House of Commons Science and
Technology Committee, accessed 29 January 2009
- Scientists want new drug rankings, BBC News
website, 23 March 2007, accessed 27 January 2009
- Controlled Drugs and Substances Act,
Department of Justice website, accessed 9 February 2009
- Misuse of Drugs Act 1975, New Zealand
website, accessed 9 February 2009
- Misuse of Drugs Act 1977, Office of the Houses of
the Oireachtas website, accessed 9 February 2009
- Misuse of Drugs Act 1984, Irish Government
website, accessed 9 February 2009
- Drugs Act 2005 (c. 17), OPSI website,
accessed 2 February 2009
- Controlled Substances Act (short title),
U.S. Food and Drug Administration website, accessed 6 February
2009